Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-05-16

Clinical Trial Update: Hydroxyapatite Active Pro Healing Clinical Trial Program [NA]

View source ↗

Summary

Clinical trial program for Hydroxyapatite Active Pro Healing developed by BioSync Scientific Pvt. Ltd. targets Coronary Artery Disease. The current trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyapatite Active Pro Healing

Snippet

Sponsor: BioSync Scientific Pvt. Ltd. | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN